Examination of top DEG pathways downstream of KCa3.1 inhibition with cellular processes known to be involved in atherosclerosis reveals a novel model of the mechanisms underlying KCa3.1 silencing inhibiting atherosclerotic lesion development and altering plaque composition (Figure 5(D)). Here, KCNN4 is linked to atherosclerosis.